GlassScriptPhysician profile
Kelly Chasin
NPI 1023330297
$227.32
in general payments reported to CMS, 2019-2025
9 companies · $28.31 in 2025
The $28.31 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.45 · 2022: $72.30 · 2023: $59.48 · 2024: $20.78 · 2025: $28.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $108.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $72.30 | 2022 | |
| Adlon Therapeutics L.P. | $31.04 | 2021 | |
| Phadia US INC. | $25.55 | 2023 | Immunocap |
| Biomarin Pharmaceutical INC. | $20.78 | 2024 | Voxzogo 1.2mg |
| Pfizer INC. | $17.86 | 2023 | |
| Merck Sharp & Dohme LLC | $16.07 | 2023 | Vaxneuvance, Proquad, M-M-R II |
| Oxford Immunotec USA INC | $15.41 | 2021 | |
| Cranial Technologies, INC | $14.41 | 2025 | Doc Band |
| Vertical Pharmaceuticals, LLC | $13.90 | 2025 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Chasin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.